James George Robinson is Director at NYMOX PHARMACEUTICAL CORP (NYMX). They have made 89 open-market trades across 3 companies since 2015, most recently 2023-04-27.
CIK 0001651844
89 open-market purchases totalling $8.0M since 2015, never a sale. Across 85 scored buys the stock is up 8.6% at ninety days, and 6.5 points ahead of the S&P over the same stretch.
85 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 31% | 41% | 66% |
| Avg Move | -4.0% | -3.4% | +8.6% |
| Alpha | -3.4% | -3.0% | +6.5% |
| Scored | 85 | 85 | 85 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NYMX | BUY | 2023-04-25 | 2023-06-26 | $0.46 | $37K | N/A | N/A | N/A |
| ALID | BUY | 2023-04-25 | 2023-04-27 | $0.46 | $37K | N/A | N/A | N/A |
| NYMX | BUY | 2022-05-02 | 2022-05-06 | $1.65 | $3.8M | -9.7% | -73.6% | -72.9% |
| NYMX | BUY | 2021-04-21 | 2021-04-27 | $2.08 | $83K | -15.6% | -21.2% | -38.7% |
| NYMX | BUY | 2019-07-10 | 2019-07-12 | $1.73 | $12K | -2.3% | -0.6% | +17.1% |
| NYMX | BUY | 2019-07-09 | 2019-07-10 | $1.63 | $11K | -8.6% | +1.1% | +11.4% |
| NYMX | BUY | 2019-07-05 | 2019-07-09 | $1.45 | $13K | -1.8% | +7.9% | +23.0% |
| NYMX | BUY | 2019-07-03 | 2019-07-03 | $1.54 | $12K | +20.4% | +31.0% | +28.9% |
| NYMX | BUY | 2019-07-01 | 2019-07-02 | $1.37 | $13K | +3.2% | +20.4% | +16.6% |
| NYMX | BUY | 2019-06-28 | 2019-07-01 | $15.16 | $152K | +19.9% | +17.8% | +25.3% |
| NYMX | BUY | 2019-06-27 | 2019-06-28 | $1.56 | $14K | +19.2% | +15.1% | +32.9% |
| NYMX | BUY | 2019-06-26 | 2019-06-27 | $1.71 | $14K | +9.6% | +7.7% | +23.1% |
| NYMX | BUY | 2019-06-25 | 2019-06-26 | $1.73 | $16K | +2.5% | +5.5% | +16.0% |
| NYMX | BUY | 2019-06-20 | 2019-06-21 | $1.77 | $16K | -22.8% | -15.3% | +11.9% |
| NYMX | BUY | 2019-06-19 | 2019-06-20 | $1.69 | $14K | -17.5% | -12.6% | +8.7% |
| NYMX | BUY | 2019-06-18 | 2019-06-19 | $1.67 | $15K | -23.4% | -12.0% | +4.9% |
| NYMX | BUY | 2019-06-13 | 2019-06-18 | $1.42 | $11K | -12.7% | -0.6% | +15.1% |
| NYMX | BUY | 2019-06-11 | 2019-06-12 | $1.47 | $14K | +29.1% | +30.6% | +34.3% |
| NYMX | BUY | 2019-06-10 | 2019-06-12 | $1.54 | $12K | +29.1% | +30.6% | +34.3% |
| NYMX | BUY | 2019-06-06 | 2019-06-07 | $1.56 | $16K | +21.3% | -2.0% | +14.7% |
| NYMX | BUY | 2019-06-05 | 2019-06-06 | $1.55 | $17K | +13.9% | -0.7% | +10.8% |
| NYMX | BUY | 2019-06-03 | 2019-06-04 | $1.62 | $15K | -1.8% | -12.7% | +0.0% |
| NYMX | BUY | 2019-05-31 | 2019-06-04 | $1.59 | $16K | -1.8% | -12.7% | +0.0% |
| NYMX | BUY | 2019-05-30 | 2019-05-31 | $1.76 | $15K | -18.9% | -14.0% | +3.6% |
| NYMX | BUY | 2019-05-28 | 2019-05-30 | $1.68 | $15K | -9.8% | -14.0% | +3.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.